Yes, with meaningful nuance: HG, the most severe form of pregnancy sickness, runs in families at rates that point to a strong inherited component, and researchers have pinpointed specific gene variants, most notably in GDF15, that shape who stays vulnerable. Twin studies estimate the heritability of HG at roughly 70 to 80 percent, meaning most variation in risk traces back to DNA rather than environment alone.
Your grandmother’s weeks of unrelenting vomiting, your sister’s feeding tube during her second trimester, your own first pregnancy spent unable to keep water down: those patterns are not coincidence.
What follows covers how hereditary risk differs from specific genetic mechanisms, what your family tree actually predicts, and how to use that knowledge before and during pregnancy. Whether you are planning a first pregnancy or recovering from a prior HG experience, this breakdown gives you a working framework for the next conversation with your provider.
Understanding Hyperemesis Gravidarum Beyond Morning Sickness
Most people associate early pregnancy with queasy stomachs and food aversions that fade by the second trimester. HG breaks that pattern dramatically. Clinicians define HG by persistent vomiting severe enough to cause dehydration, weight loss exceeding 5 percent of pre-pregnancy body weight, and the inability to maintain nutrition or hydration without medical support. Hospital admission is common, and the condition can last well past week 14.
How HG Differs From Typical Nausea and Vomiting in Pregnancy
Up to 80 percent of pregnant women experience some nausea and vomiting in pregnancy (NVP), the umbrella term for what is casually called morning sickness. That experience stays uncomfortable but manageable: queasiness triggered by smells, occasional vomiting, and a return to normal eating within weeks. HG sits at the far end of that spectrum. Vomiting becomes daily, often hourly. Weight drops. Blood work reveals electrolyte imbalances.
Some patients develop Mallory-Weiss tears in the esophagus from retching; others require intravenous fluids or feeding tubes to stay alive through pregnancy.
Why the Distinction Matters for Genetic Research
Scientists studying DNA variants linked to pregnancy sickness specifically recruit women diagnosed with HG, not those with garden-variety queasiness. The genetic signal they hunt for corresponds to severe cases, not the broad population of women who feel mildly nauseated in week eight. That recruitment choice explains why a study might report a strong genetic link to HG while saying little about average pregnancy nausea.
When your provider asks whether your mother or sister had HG specifically, the precision of that question matters for your risk estimate.
The Familial Pattern: How Heredity Shapes HG Risk
The twin-study evidence tells a striking story. Researchers have compared identical twins (who share nearly 100 percent of their DNA) with fraternal twins (who share roughly 50 percent) and found HG concordance far higher in identical pairs. The resulting heritability estimate, the proportion of risk attributable to genetic differences between people, lands between 70 and 80 percent. Few common conditions show that strong a genetic fingerprint, which is why family history carries real predictive weight in clinical counseling.
Recurrence Risk Across Family Relationships
Familial clustering matters most when quantified, not just observed. Population-wide, HG affects roughly 0.3 to 2 percent of pregnancies, depending on diagnostic criteria and population studied. Among women with an affected first-degree relative, that number climbs sharply:
| Relationship to an Affected Woman | Approximate HG Risk |
|---|---|
| General population (no known family history) | 0.3–2% |
| Daughter of a mother who had HG | Up to ~25–30% |
| Sister of a woman who had HG | ~17–20% |
| Twin sister (identical) of an affected twin | ~70%+ |
These numbers come from peer-reviewed cohort studies, including work led by researcher Marlena Fejzo at the University of Southern California, whose team has tracked HG families for decades. The pattern stays consistent: the closer the genetic relationship to an affected woman, the higher your personal risk climbs.
Maternal-Line Versus Paternal-Line Patterns
Available evidence leans toward maternal-side patterns being stronger than paternal-side, though the mechanism is not entirely settled. One explanation involves mitochondrial DNA, inherited only from the mother, which plays a role in cellular energy metabolism and may influence how placental cells behave. Another possibility is that maternally inherited gene variants, including those controlling immune signaling at the maternal-fetal interface, shape the hormonal environment of early pregnancy.
Paternal family history is not irrelevant, but most published family-history studies report larger effect sizes when the affected relative sits on the mother’s side.
The Genetic Layer: GDF15 and Other Variants Linked to HG
Heredity describes who in a family is affected. Genetics describes the specific DNA changes behind that clustering. In HG, the most important gene identified so far is GDF15, which encodes a signaling protein called growth/differentiation factor 15. This protein acts on receptors in the brainstem that control nausea, appetite, and vomiting. In pregnancy, the placenta is a major source of GDF15, and circulating levels of this protein surge in the first trimester, precisely when HG symptoms typically peak.
The GDF15 Receptor and How the Signal Reaches the Brain
GDF15 does not float through the bloodstream aimlessly. It binds to a specific receptor called GFRAL, located in a small region of the brainstem called the area postrema, sometimes called the brain’s “vomiting center.” When GDF15 binds GFRAL, it triggers the sensation of nausea and suppresses appetite. People who carry versions of GDF15 or GFRAL that produce more protein, or whose brains are more sensitive to the signal, may experience far stronger nausea responses during the natural first-trimester surge.
What Genome-wide Association Studies Found
Two gene regions, GDF15 itself and the nearby IGFBP7, emerged as significant associations when genome-wide association studies compared thousands of HG patients with unaffected pregnant controls in 2018 and follow-up years, implicating placental development and nausea-signaling pathways. Carrying the risk-associated variants raises the odds of HG substantially, but does not guarantee it. Many women without HG also carry these variants, and many women with HG do not have the strongest risk genotype.
Carrying a GDF15 risk variant raises your statistical odds of HG, but pregnancy hormones, nutritional status, and multiple gestation interact with those variants to determine whether the genetic risk becomes clinical disease.
Why Carrying a Risk Variant Is Not Destiny
Genes set the stage. Pregnancy hormones, particularly human chorionic gonadotropin (hCG) and estrogen, decide whether the curtain rises. GDF15 risk variants affect how strongly your body responds to the placental GDF15 surge, but they cannot trigger symptoms on their own. A woman with the highest-risk genotype who never becomes pregnant will never develop HG. The genes act only in the specific hormonal context of early gestation.
Hormones, Pregnancy, and How Genes Become Symptoms
The placenta is a temporary organ that produces dozens of hormones, and its output in the first trimester is what makes HG possible. Three hormonal signals interact with genetic predisposition to determine severity: hCG, estrogen, and placental GDF15 itself. Each one peaks at a slightly different time, and together they shape the nausea curve that defines the first half of pregnancy.
Peak Symptom Windows and the First-Trimester Surge
HG symptoms typically begin between weeks 4 and 7 of gestation and worsen until weeks 9 to 13, when hCG and GDF15 levels peak. After week 14, levels decline for most women, though a substantial minority of HG patients continue vomiting well into the second and third trimesters.
The timing of symptom onset and resolution tracks the hormone curves more closely than it tracks any single genetic variant, which is why symptom diaries often reveal more than a single genetic test result.
Compounding Risk Factors That Interact With Genetics
Even with a strong family history, additional factors shape your actual risk:
- Multiple gestation: Twin or triplet pregnancies produce roughly twice the placental hormone output, raising both baseline and HG-related risk.
- Prior HG history: Women who had HG in a first pregnancy face recurrence rates exceeding 75 percent in subsequent pregnancies.
- Female fetus: Some studies suggest slightly higher HG rates when carrying a female fetus, possibly tied to higher hCG levels.
- Nutritional status: Pre-pregnancy low BMI and certain micronutrient patterns correlate with more severe symptoms.
- Ethnicity and geography: HG rates vary across populations, suggesting both genetic background and dietary or environmental influences.
Assessing Your Personal Risk Profile
Family history remains the most accessible risk-assessment tool available today. Genetic testing for HG-specific variants has not yet entered standard clinical practice, and most commercial panels do not include GDF15 or IGFBP7 markers. That gap makes documenting your family tree, in clinically useful language, the most practical step you can take before conception.
How to Document Family History for a Provider
Walk through each female relative on both sides of your family and note whether she experienced severe nausea and vomiting during pregnancy. Distinguish between “some queasiness” and “could not keep water down,” “lost more than 10 pounds,” “was hospitalized,” or “needed a feeding tube.” Severity in relatives predicts severity in you. Record which pregnancies were affected, because HG can skip a pregnancy and return in the next, even in the same woman.
Questions to Bring to a Preconception or Early-Pregnancy Visit
Arrive with a written list so nothing gets lost in a short appointment:
- Family history details: Bring the documented family tree with severity notes.
- Personal history: Mention any prior pregnancy with severe nausea, even if not formally diagnosed as HG.
- Recurrence questions: Ask what monitoring plan your provider recommends given your risk profile.
- Early-intervention options: Ask what symptoms should trigger an immediate call rather than a scheduled visit.
- Research updates: Ask whether GDF15 or related biomarker testing is appropriate or available through research programs.
Turning Risk Knowledge Into Action Before and During Pregnancy
Knowing your risk is useful only if it changes your care. Preconception counseling with a maternal-fetal medicine specialist gives you a baseline plan: what to monitor, when to escalate, and how to respond when symptoms appear. Guidance from the American College of Obstetricians and Gynecologists (ACOG) supports early, proactive management for women with prior HG or strong family history, which gives you a clinical framework to cite if your provider hesitates.
Early-Intervention Strategies
Track symptoms daily from the moment you suspect pregnancy. Use a simple scale, rating nausea from 0 to 10 and recording any vomiting episodes. Share the log with your provider at each visit. The goal is to escalate care before dehydration sets in, not after. Nutritional safeguards matter: small, frequent meals; bland carbohydrates; electrolyte replacement; and a clear threshold for IV fluids when oral intake fails.
None of these strategies require advanced technology; they require a plan made before symptoms hit.
Myths That Distract From Real Planning
Two persistent myths deserve correction. First, HG is not psychological. Decades of research have shown that severe pregnancy sickness has measurable biological mechanisms, primarily hormonal and genetic, and framing it as a mind-over-matter issue delays care. Second, an unaffected prior pregnancy does not guarantee safety in a future one. HG can appear for the first time in a second or third pregnancy, particularly if hormonal conditions differ, such as a change in fetal sex or a multiple gestation.
Your next step is a preconception visit where you walk in with a documented family tree, a clear list of questions, and a plan for symptom tracking from week one of any future pregnancy.
Bottom Line
HG clusters in families because specific DNA variants, most notably in GDF15, change how your brain responds to the hormonal surge of early pregnancy. That genetic risk, layered with family history and pregnancy-specific triggers, explains why some women endure months of relentless vomiting while others barely feel queasy. Document your family history, bring it to a provider before conception, and use the knowledge to design an early-intervention plan rather than waiting for symptoms to escalate.
FAQ
Is hyperemesis gravidarum passed down from mother to daughter?
Yes, maternal transmission is the strongest documented familial pattern. Daughters of women who had HG face roughly 25 to 30 percent risk in their own pregnancies, compared with 0.3 to 2 percent in the general population.
What genes are linked to hyperemesis gravidarum?
The strongest genetic links are to GDF15, which encodes a nausea-signaling protein, and IGFBP7, which affects placental development. Both were identified through genome-wide association studies of HG patients.
If my mother had severe morning sickness, will I have it too?
Not necessarily, but your risk is meaningfully higher. Severity in your mother predicts severity in you. Tracking symptoms from week one of pregnancy and escalating early gives you the best chance of avoiding the worst outcomes.
Can hyperemesis gravidarum skip a generation?
Yes. HG can appear in a daughter whose mother had only mild nausea, and it can appear in a second pregnancy when a first was unaffected. Skipped generations do not rule out inherited risk.
How likely am I to have hyperemesis gravidarum if my sister had it?
Estimates suggest roughly 17 to 20 percent of sisters of affected women develop HG themselves, several times the population baseline. Combined with your own prior pregnancy history, this becomes a meaningful planning factor.
